Lv6
2600 积分 2025-03-19 加入
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
2天前
已完结
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
2天前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
8天前
已完结
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial
16天前
已完结
Deucravacitinib shows superior efficacy and safety in cutaneous lupus erythematosus compared to various biologics and small molecules – A systematic review and meta-analysis
18天前
已完结
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus
18天前
已完结
The efficacy of novel B cell biologics as the future of SLE treatment: A review
18天前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
18天前
已完结
Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus
19天前
已完结
Incidence and prevalence of multiple sclerosis in China and other Asian countries
23天前
已完结
皖公网安备34019202002308
